Skip to main content
OpenTrials

Clinical trial condition

HNSCC

Explore clinical trials studying HNSCC. Study availability and eligibility vary by location and protocol.

78 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

HNSCC trial results

Completed

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

NCT04997902

Conditions
Carcinoma, Carcinoma, Squamous Cell, Congenital Abnormalities, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Lake Nona DDU (Florida Cancer Specialists) Orlando, Florida, United States
  • University of Maryland School of Medicine (Marlene and Stewart Greenebaum Comprehensive Cancer Center) Baltimore, Maryland, United States
  • Johns Hopkins University School of Medicine (Sidney Kimmel Comprehensive Cancer Center) Baltimore, Maryland, United States
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details

Related conditions